Details of the Drug Reposition

General Information of This Drug (ID: DM1BRWD)

Drug Name
Concizumab   DM1BRWD
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Haemophilia A DIS0RQ2E 3B10.0 Phase 3 [1]
Haemophilia B DIS6KF0Q 3B11.0 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT05135559) Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without Inhibitors. U.S.National Institutes of Health.